The Patent Finder

Reduced Size Self-Delivering Rnai Compounds (2011)

Phio Pharmaceuticals Corp.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/US2009/005247, filed Sep 22, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,175,289Reduced Size Self-Delivering Rnai Compounds
In force
 · Medium confidence
Phio Pharmaceuticals Corp.In force
Medium confidence
US 10,774,330Reduced Size Self-Delivering Rnai Compounds
In force
 · Medium confidence
Phio Pharmaceuticals Corp.In force
Medium confidence
US 8,796,443Reduced Size Self-Delivering Rnai Compounds
In force
 · Medium confidence
Phio Pharmaceuticals Corp.In force
Medium confidence
US 10,876,119Reduced Size Self-Delivering Rnai Compounds
Lapsed Dec 29, 2024 on the fee record
Ended Dec 29, 2024 · Medium confidence
Phio Pharmaceuticals Corp.Lapsed Dec 29, 2024 on the fee recordEnded Dec 29, 2024
Medium confidence
US 10,041,073Reduced Size Self-Delivering Rnai Compounds
Lapsed Aug 7, 2026 on the fee record
Ended Aug 7, 2026 · Medium confidence
Phio Pharmaceuticals Corp.Lapsed Aug 7, 2026 on the fee recordEnded Aug 7, 2026
Medium confidence
Application 16/934,864Reduced Size Self-Delivering Rnai Compounds
Pending
Not granted
Phio Pharmaceuticals Corp.PendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Phio Pharmaceuticals Corp..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited